AKT1 and telomere syndrome: For example, MK-2206 and eribulin, a microtubule dynamics inhibitor, synergistically inhibited STS cell growth in vitro and in vivo, also revealing a rationale for the development of an AKT inhibitor in combination with eribulin for therapy of patients with STS [39].